SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-011191
Filing Date
2022-03-09
Accepted
2022-03-09 06:20:45
Documents
103
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_purplebiotech.htm   iXBRL 20-F 2546903
2 DESCRIPTION OF SHARE CAPITAL f20f2021ex2-1_purplebiotech.htm EX-2.1 142672
3 PURPLE BIOTECH LTD. 2016 EQUITY-BASED INCENTIVE PLAN, AS AMENDED f20f2021ex4-3_purplebiotech.htm EX-4.3 172752
4 LIST OF SUBSIDIARIES OF THE REGISTRANT f20f2021ex8-1_purplebiotech.htm EX-8.1 11044
5 CERTIFICATION BY CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES f20f2021ex12-1_purplebiotech.htm EX-12.1 11390
6 CERTIFICATION BY CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES f20f2021ex12-2_purplebiotech.htm EX-12.2 11602
7 CERTIFICATION BY CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES f20f2021ex13-1_purplebiotech.htm EX-13.1 4794
8 CERTIFICATION BY CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES f20f2021ex13-2_purplebiotech.htm EX-13.2 4797
9 CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB f20f2021ex15-1_purplebiotech.htm EX-15.1 3107
10 GRAPHIC image_001.jpg GRAPHIC 32376
11 GRAPHIC image_002.jpg GRAPHIC 12889
  Complete submission text file 0001213900-22-011191.txt   8633347

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE ppbt-20211231.xsd EX-101.SCH 111419
13 XBRL CALCULATION FILE ppbt-20211231_cal.xml EX-101.CAL 34574
14 XBRL DEFINITION FILE ppbt-20211231_def.xml EX-101.DEF 304455
15 XBRL LABEL FILE ppbt-20211231_lab.xml EX-101.LAB 629916
16 XBRL PRESENTATION FILE ppbt-20211231_pre.xml EX-101.PRE 315863
97 EXTRACTED XBRL INSTANCE DOCUMENT f20f2021_purplebiotech_htm.xml XML 975568
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37643 | Film No.: 22723864
SIC: 2834 Pharmaceutical Preparations